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Abstract: It is known that estrogens act on the male reproductive tract by binding to estrogen receptors (ER) a and
b. However, studies on ER localization in the human testis are discordant. The aim of this study was to investigate
the localization of ERa in the testes of adult men with normal spermatogenesis. Semen analysis of ten adult men
revealed azoospermia. FSH, LH and testosterone serum concentrations were within normal values, and the vol-
ume of the testes was normal, hence obstructive azoospermia was suspected. The tissues from testicular surgical
biopsies were fixed in Bouin’s fluid and embedded in paraffin. Assessments of the seminiferous epithelium (scor-
ing 10 to –1), the number of Leydig cells (scoring 1 to 5), the areal fraction of intertubular space (IS), measure-
ments of seminiferous tubule diameter, and the thickness of the tubular wall, were performed on microscopic
sections. Immunohistochemical staining was applied with monoclonal antibodies against ERa. The mean sper-
matogenesis score was 10 points; IS — 30.6 ± 8.1%; seminiferous tubule diameter — 193.9 ± 19.4 μm; thickness of
tubular wall — 7.44 ± 1.1 μm; number of Leydig cells — 1.6 ± 1.1 points. Immunohistochemical staining showed
the localization of ERa to be in the Sertoli and Leydig cell cytoplasm, while ERa was absent in germ cells. The
results of testicular tissue analysis confirmed its normal structure and normal, full spermatogenesis. The presence
of ERa in Sertoli and Leydig cells in normal human testis demonstrated in this study suggests that estrogens may
affect testicular function. (Folia Histochemica et Cytobiologica 2012, Vol. 50, No. 3, 340–345)
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Introduction
Estrogens act on the target tissue by means of bind-
ing to an estrogen receptor (ER), which is a member
of the nuclear receptor superfamily. Upon binding to
ER, the ligand causes conformational changes in the
receptor structure, followed by its dimerization. The
activated receptor interacts with DNA, specifically
with estrogen responsive elements (EREs), resulting
in the transcription of target genes [1]. Nowadays, it
is known that ERs can also modulate gene expres-
sion without direct binding to DNA [2].
Two main types of ER can be distinguished: a and b
(also called ER1 and ER2, respectively). Both ER
types consist of six distinct regions (A–F). ERa and
ERb are, to some extent, similar in structure and have
high amino acid homology, especially in the DNA-
-binding and ligand-binding domains, which corre-
spond to regions C and E, respectively. Although most
ligands have similar binding and transcriptional po-
tency for ERa and ERb, some ligands are more spe-
cific for one ER type. For example, tetrahydrochry-
sene is an agonist of ERa and an antagonist of ERb,
and aryl-substituted pyrazole shows a higher binding
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affinity for ERa and stimulates it more than 100 times
more effectively than ERb [3].
Generally, ERs are abundantly distributed in many
tissues and organs such as the central and peripheral
nervous system, skeleton, lungs, and the cardiovas-
cular and reproductive systems of females and males
[4–6]. Studies with ER knock-out (ERKO) mice
showed that a lack of receptors leads to infertility [7]
and deficient sexual behaviour in males [8]. Both ER
types are widely distributed in the male reproductive
system, although ERb seems to be prevalent. Both
ER types are present in the epididymis of pigs, rats
and monkeys [9–11], however, in humans, ERb seems
to be more prevalent [12]. The prostate in humans
and rats contains mainly ERb, while ERa is rarely
detectable [10, 13].
The exact localization of ERa and ERb in the tes-
tis is still uncertain and seems to be species- and age-
dependent, e.g. ERa and ERb localization changes
during the lifespan of rodents and stallions [14, 15].
According to Hejmej et al. [16] the presence of ERa
in stallions is limited to Leydig cells during the neo-
natal and peripubertal periods of life. In the bank vole
(independently of the animal’s age) ERa presence
was observed in Leydig cells while ERb was present
in Sertoli cells, and also in the nuclei of spermato-
cytes and elongated spermatids of animals exposed
to long light cycles [17]. Recently, it has been shown
that ERa was present in spermatids and Sertoli cells
of descended testes, and also in Leydig cells of cryp-
torchid testes of rats [18]. In turn, Pelletier et al. [19]
localized ERa in rats in the nuclei of Leydig cells, as
well as in round spermatocytes and spermatids. ERb
was only detected in Sertoli cell nuclei. Other authors
have observed expression of ERb in rat germ and so-
matic cells (Leydig or Sertoli cells) [20, 21]. During
the perinatal period ERb mRNA and ERb protein
were demonstrated in fetal germ cells, i.e. gonocytes
(data for rats aged four days), in spermatogonia A
and pachytene spermatocytes (data for rats aged
10–26 days) [21].
Regarding human models, Makinen et al. [22]
showed that ERb was the only ER type observed in
the human testis (in nuclei of spermatogonia, sper-
matocytes and early spermatids). Enmark et al. [23]
confirmed the localization of ERb in spermatids, while
Cavaco et al. [24] found that ERb was localized in
Leydig cells, spermatocytes, spermatids and sperma-
tozoa. Shapiro et al. [25] found both ERa in Leydig
cells and ERb in germ and Leydig cells of human fe-
tal testis. In contrast, Boukari et al. [26] demonstrat-
ed the presence of only ERb in human fetal testis since
ERa was not detected in their study.
The inconsistency of the reports on ERa localiza-
tion in the human testis (for a review, see [27, 28])
may be due to the lack of homogeneity of the exam-
ined groups, i.e. different abnormalities in spermato-
genesis. The aim of this study was to determine the
testicular localization of ERa in young adult men with
confirmed normal spermatogenesis.
Material and methods
The retrospective study was performed with the approval
of the Bioethical Committee of the Medical University of
Lodz (Poland). Ten men, aged 25–39 years (median 32),
were included in this study. Their clinical documentation
was obtained from the Outpatients Clinic of Andrology and
Reproductive Endocrinology in Lodz (Poland), to which the
patients were referred due to infertility.
In all subjects, semen analysis was performed according
to WHO guidelines [29]. The azoospermia was assessed in
each patient; otherwise all patients were healthy. In all pa-
tients, the testicular volume measured by means of ultra-
sonography was normal (> 12 ml), and the structure of the
testes was homogeneous. Serum concentrations of hor-
mones were measured in the Department of Hormonal Di-
agnostics in Lodz (Poland) using a chemiluminesence im-
munoassay (Immulite 1000, DPC, USA). The detection lim-
its were 0.5 nmol/l for total testosterone, 0.1 IU/L for FSH,
and 0.1 IU/L for LH. Reference values in the Department
of Hormonal Diagnostics are as following: testosterone —
7.5–28.2 nmol/l, FSH — 1.55–9.47 mIU/ml and LH —
0.83–15.5 mIU/ml [30].
All patients underwent unilateral or bilateral surgical
testicular biopsy in the course of the diagnostic procedure
for infertility. Archival material of these patients’ testes, em-
bedded in paraffin and stored in the Department of An-
drology and Reproductive Endocrinology, Medical Univer-
sity of Lodz, was used for the study.
Histology and immunohistochemistry. Tissues were fixed
in Bouin’s solution and embedded in paraffin. Each biopsy
was completely serially sectioned. The sections, 5 μm thick,
were stained with hematoxylin and eosin and examined us-
ing a light microscope (Eclipse E 600, Nikon, Japan).
For immunohistochemistry, the sections were heated in
citrate buffer, pH = 9.0 for 30 min. in a water bath at 96°C.
The sections were next incubated for 30 min at room tem-
perature in a humidified chamber with monoclonal mouse
anti-human ERa antibody (N 1575, Dako Cytomation, Glos-
trup, Denmark). The detection of the anti-ERa antibody
was performed using a Dako LSAB 2 KIT/HRP kit. Amino-
ethylocarbazole (AEC substrate chromogen) was used to vi-
sualize the immunohistochemical reaction. Finally, the sec-
tions were counterstained with Mayer’s hematoxylin. After
each step, the sections were rinsed with Tris-buffered saline
(TBS). The negative control sections were incubated with TBS
instead of the primary antibody. Sections of ovarian tissues
from postmenopausal women served as positive control [31].
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Assessment of spermatogenesis and Leydig cells. Spermato-
genesis and the seminiferous epithelium were scored on
a scale of –1 to 10 according to a modification of De Kretser
and Holstein’s method [32], presented in a previous study
[33]. A score of 10 points was considered to be full, intact
spermatogenesis, while a lower score indicated a deterio-
rating seminiferous epithelium. In each biopsy, 50–100 cross-
sections of seminiferous tubules were evaluated and a mean
number of points was assigned to the biopsy specimen.
The number of Leydig cells in the triangular intertubu-
lar spaces was assessed on a scale of 1–5 according to Gu-
minska et al. [33]. Based on observations from our own and
other studies, a number of Leydig cells higher than 2 points
was considered to be abnormal [34]. In each biopsy, 100
triangular intertubular spaces were evaluated and a mean
number of points was assigned to the biopsy specimen.
Morphometry. Morphometric analyses were performed us-
ing LxAND v3.60HM image analysis software (Logitex, Lodz,
Poland). Seminiferous tubule diameter, thickness of tubular
membrane and the areal fraction of intertubular space (IS)
were evaluated. The IS value indicates the percentage area
of the intertubular compartment within the area of the histo-
logical section of the testicular biopsy [35]. The microscopic
image at 100 × magnification was covered by a square lattice
containing 441 intersections. The number of intersections
projecting on the intertubular spaces was counted by a sys-
tematic movement across the grid over the entire tissue sec-
tion. The IS value was calculated by dividing the number of
intersections which fell on the intertubular spaces by the num-
ber of intersections within the whole field of vision at the
same magnification, and multiplied by 100.
All the measurements were performed in ten random-
ly-selected histological sections of one gonad in each pa-
tient and are shown as a mean ± SD. The following values
were recognized as abnormal: tubular diameter < 150 μm,
thickness of tubular wall > 10 μm, IS > 40%. The normal
values of the diameter of seminiferous tubules, thickness of
tubular wall and interstitial spaces were defined based on
previous reports [33, 34, 36, 37].
Statistics. All statistical analyses were performed using Sta-
tistica 8.0 software (StatSoft, Krakow, Poland).
Results
Measurements of FSH, LH and testosterone serum
concentrations revealed normal values (Table 1).
The assessment of the spermatogenesis score and
Leydig cell score, as well as the morphometric analy-
sis of testicular structure, revealed values typical for
normal adult testes (Table 1) [33, 36, 37].
ERa immunostaining was found in the cytoplasm of
Sertoli and Leydig cells (Figure 1). The nuclei of germ
cells (spermatogonia, spermatocytes, round and elongat-
Table 1. Serum hormone concentrations, testicular volume
and morphometry of testicular structures in ten adult men
with obstructive azoospermia
Parameters Mean ± SD
FSH [IU/L] 5.28 ± 2.7
LH [IU/L] 4.6 ± 2.6
Testosterone [nmol/L] 15.95 ± 6.0
Testicular volume [ml] 16.8 ± 3.2
Spermatogenesis advance (points) 10
Seminiferous tubules diameter [μm] 193.9 ± 19.4
Thickness of tubular membrane [μm] 7.44 ± 1.1
Areal fraction of intertubular spaces (%) 30.6 ± 8.1
Number of Leydig cells (points) 1.6 ± 1.1
Figure 1. Positive ERa immunostaining of testis (red color)
with normal structure and full spermatogenesis is clearly
visible in Sertoli and Leydig cells’ cytoplasm. Some
immuno- reactivity seen in the lumen of the tubule or
nearby presents an artifact
Sg — nuclei of spermatogonia; Sc — nuclei of spermatocy-
tes; Spr — nuclei of round spermatids; Spe — nuclei of
elongated spermatids; M — nuclei of myoid cells; L —
nuclei of Leydig cells; S — nuclei of Sertoli cells; L-ERa+ —
staining positive for ERa in Leydig cells cytoplasm; S-ERa+
— staining positive for ERa in Sertoli cells cytoplasm
ed spermatids, spermatozoa) were not immunoreactive
for ERa. Some immunoreactivity seen in the lumen of
the tubule or nearby has been assessed as an artifact due
to reallocation of seminiferous epithelium from another
part of the tubule during testicular biopsy.
Discussion
Our study revealed ERa immunolocalization in Ser-
toli and Leydig cells in human testes with normal
structure and full spermatogenesis. This is in accor-
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dance with the results of Taylor and Al-Azzawi [38]
who found ERa in Sertoli and Leydig cells of humans.
Nevertheless, the results of studies on ERa localiza-
tion in testes shown in the literature are discordant.
They can vary depending on the method used to de-
termine the presence of ER. Additionally, receptor
localization varies between species. In humans, the
most extreme approaches were presented by Makin-
en et al. [22] and Cavaco et al. [24]. Makinen et al.
suggested that ERa is not present in human testes,
while Cavaco et al. demonstrated their presence in
all germ cell types, as well as in Sertoli and Leydig
cells. Interestingly, both authors examined subjects
of similar age and both had samples taken from pa-
tients with obstructive azoospermia, Sertoli cell-only
syndrome and hypospermatogenesis. Both studies
applied immunohistochemical methods to verify ERa
localization and were supported by the analysis of
ERa mRNA expression (by means of RT-PCR). The
analysis performed by Cavaco et al. [24] showed that
ERa mRNA was found in the testes of men present-
ing both normal and disrupted spermatogenesis and
that it was relatively constant for men with normal
spermatogenesis. Makinen et al. [22] did not detect
ERa mRNA in the testicular tissue of men with nor-
mal spermatogenesis, as well as hypospermatogene-
sis and Sertoli cell-only syndrome. This contradicto-
ry result might be due to some methodological issues.
Makinen et al. amplified the samples in 35 cycles,
while Cavaco et al. amplified the samples in 37 cy-
cles, which might be the reason for better detection.
Moreover, the different authors used different kits
for total RNA isolation from the tissue and different
antibodies for immunohistochemistry, as well as dif-
ferent dilutions of the antibodies.
Similar to Makinen et al. [22], Saunders et al. [12]
did not detect ERa protein in human testes (men with
non-obstructive azoospermia and after vasectomy)
nor primates (marmoset and macaque), although they
claimed to find immunolocalized ERa in Leydig cells
of rat testes (however, the data was not shown and
only mentioned by the authors). Saunders et al. per-
formed ERa immunolocalization by means of the
same antibodies as used by Makinen et al. and they
confirmed the results by Western blotting, although
they did not use RT-PCR. In turn, Pelletier and El-
Alfy [39] observed ERa only in human Leydig cells
with no tubular labeling. Strong positive staining for
ERa was observed also with the use of a rabbit poly-
clonal antibody to human ERa in early meiotic germ
cells, namely zygotene and early pachytene primary
spermatocytes and in early elongating spermatids [40].
Lambard et al. [41] identified an ERa isoform vari-
ant that lacks exon 4 in human germ cells with the
application of RT-PCR with specific primers and by
Western blotting using monoclonal antibodies. In
addition, another transcript to the exon I-deleted vari-
ant was detected [42]. Thus, either the presence or
the absence of ER isoforms (full length or variants)
is likely to be related to the various antibodies used,
as well as to the origin of the tissues.
The presence of ERb in the testis has been shown
by many authors. Based on the results showing that
the only ER type present in the testis is ERb [12, 43],
one may conclude that estrogens exert their effect on
testes acting exclusively by binding to ERb. Howev-
er, the demonstration of ERa presence in the human
testis by other immunohistochemical studies [25, 38],
is in contrast with the above mentioned hypothesis
and indicates that probably both ERa and ERb are
involved in the estrogen action pathway in the male
gonad.
For the purpose of this study, hormonal determi-
nations, spermatogenesis and Leydig cells assessments
and morphometric analysis were performed to prove
that examined testes had normal function and mor-
phology to exclude testicular disturbances. To the best
of our knowledge, this is the first study proving that
the testes examined for ER detection had normal tes-
ticular structure. Our study, which showed ERa lo-
calization in the testes with normal histological struc-
ture and function, supports the hypothesis of the in-
volvement of both types of ERs in human testis func-
tion. Our results also add weight to the opinion that
estrogens take part in the regulation of Leydig and
Sertoli cell function. Assuming that these cell types
are responsible for spermatogenesis control, estro-
gens probably have at least an indirect impact on sper-
matogenesis. However, their direct influence cannot
be ruled out and this has been postulated in studies
by other authors. Estrogens stimulate proliferation
of gonocytes [44, 45], increase the number of sper-
matogonia A [46], and stimulate DNA synthesis in
spermatogonia in the rat [47]. In human testis tissue
cultures, estradiol has been shown to act as a germ
cell survival factor [40].
The question which should be further addressed
is whether ERa and ERb patterns differ in patients
with normal and aberrant spermatogenesis. It seems
that expression of ERa mRNA is relatively constant
in the testes of patients with differing degrees of dis-
rupted spermatogenesis, while expression of ERb
mRNA varies and is lower than the expression of ERa
[24]. However, a comparison of the testes with sper-
matogenic arrest to those with normal spermatogen-
esis showed that ERa expression was lower in testes
with aberrant spermatogenesis [48]. According to the
authors, this observation may suggest that ERa (ac-
companied by androgen receptor) plays a role in the
control of spermatogenesis. Further studies are nec-
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essary to explain differences in the cellular localiza-
tion of various types of estrogen receptors in various
defects of spermatogenesis.
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